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Background: Welding, a process that generates an aerosol containing gases and metal-rich particulates,
induces adverse physiological effects including inflammation, immunosuppression and cardiovascular
dysfunction. This study utilized microarray technology and subsequent pathway analysis as an exploratory
search for markers/mechanisms of in vivo systemic effects following inhalation. Mice were exposed by
inhalation to gas metal arc – stainless steel (GMA-SS) welding fume at 40 mg/m3 for 3 hr/d for 10 d and
sacrificed 4 hr, 14 d and 28 d post-exposure. Whole blood cells, aorta and lung were harvested for global
gene expression analysis with subsequent Ingenuity Pathway Analysis and confirmatory qRT-PCR. Serum was
collected for protein profiling.
Results: The novel finding was a dominant type I interferon signaling network with the transcription factor
Irf7 as a central component maintained through 28 d. Remarkably, these effects showed consistency across
all tissues indicating a systemic type I interferon response that was complemented by changes in serum
proteins (decreased MMP-9, CRP and increased VCAM1, oncostatin M, IP-10). In addition, pulmonary
expression of interferon α and β and Irf7 specific pattern recognition receptors (PRR) and signaling
molecules (Ddx58, Ifih1, Dhx58, ISGF3) were induced, an effect that showed specificity when compared to
other inflammatory exposures. Also, a canonical pathway indicated a coordinated response of multiple PRR
and associated signaling molecules (Tlr7, Tlr2, Clec7a, Nlrp3, Myd88) to inhalation of GMA-SS.
Conclusion: This methodological approach has the potential to identify consistent, prominent and/or novel
pathways and provides insight into mechanisms that contribute to pulmonary and systemic effects
following toxicant exposure.
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Welding represents an occupation that employs over
400,000 workers fulltime in the United States and over 5
million welders worldwide. Welding uses a consumable
electrode wire to join two pieces of metal at high tempera-
tures. The process generates an aerosol containing gases
and a metal-rich particulate matter, known as the fume [1].
Therefore, an occupational health risk is present. The pri-
mary exposure route is by inhalation, and adverse effects of
welding exposure in the lung have been shown in multiple
human and animal studies [1-3]. In addition, deleterious
effects are not confined to the lung. Epidemiological studies
have shown an increased risk for ischemic heart disease in
welders [4-6]. Subsequent human and animal studies have
shown systemic inflammation and oxidative stress, vascular
dysfunction, autonomic imbalance and advanced progres-
sion of atherosclerosis as a result of welding fume exposure
[7-11]. Data also suggest that welders are immune compro-
mised and more prone to bronchitis and pneumonia [1].
Indeed, animal studies show localized pulmonary immuno-
suppression following welding fume exposure [2,12,13].
Because pulmonary exposures are associated with extra-
pulmonary effects, such as cardiovascular dysfunction,
systemic markers related to mechanisms of exposure have
the potential to be monitored. Previous studies by our
group showed a close crosstalk occurs between the pul-
monary inflammatory response and the periphery [14].
Particularly, acute increases in blood inflammatory gene
expression, altered leukocyte differentials and increased
serum inflammatory proteins were a direct reflection of
the ongoing pulmonary response following carbon nano-
tube (CNT) exposure [14,15]. These studies demonstrated
methodologies which can be applied to assess potential
systemic outcomes from a pulmonary exposure.
Occupationally derived particulate exposure levels may
produce more subtle effects compared to higher dose or
bolus lung instillation protocols, particularly when investi-
gating systemic effects. Therefore, the generation of com-
prehensive transcriptome datasets by DNA microarray,
along with gene network analysis, may prove valuable as a
preliminary search for systemic mechanisms after welding
fume exposure. In this study, microarray-derived gene net-
works from circulating whole blood cells, aorta and lung
were compared to determine related biological signaling
following inhalation of gas metal arc – stainless-steel
(GMA-SS) welding fume in mice. Also, the applicability of
this methodological approach for determining specific
exposure-induced responses was examined.
Results
Welding fume characteristics and alveolar deposition
A diagrammatic description of the robotic welder used
to generate fume for inhalation exposure and the com-
ponents of the GMA-SS fume are shown in Figure 1.The fume consists primarily of iron, chromium, manga-
nese, nickel and copper with trace amounts of silicon,
aluminum and vanadium (Figure 1). The metal solubility
in this type of fume is low (0.006 soluble to insoluble
ratio). Representative micrographs of the GMA-SS fume
are shown in Figure 1, and the mass median aero-
dynamic diameter was 0.255 μm [2]. Earlier studies have
shown that a single exposure at our experimental condi-
tions results in ~8.26 μg alveolar deposition in the lung.
Comparing to human exposures this value represents 2–
3.5 times the previous threshold limit value of 5 mg/m3
for total welding fume and 5.5-8.5 times the permissible
exposure limit value of 5 μg/m3 for hexavalent chro-
mium (CrVI) [8]. Since welding may occur in poorly
ventilated areas and measurements at the worker’s breath-
ing zone can exceed recommended exposure limits
[16,17], the exposure regimen in this study is relevant to
an occupational exposure.
Hierarchical clustering
Shown in Additional file 1: Figure S1 is the heatmap of
differentially expressed genes in the blood from C57BL/
6 J mice at 4 hr post-exposure to air or GMA-SS fume.
Similar heatmaps were generated for aorta and lung
(data not shown). Overall, expression patterns of the
analyzed genes were more similar within exposure
groups rather than between exposure groups. This indi-
cates that a good consistency across samples was found
on the individual arrays. In the blood, the annotated
genes resulted in two distinct subclusters between the
welding fume-exposed and air groups using our statis-
tical criteria (p<0.05 and fold change +/− 1.1).
Alterations in gene expression by microarray
Blood
Microarray analysis was performed on whole blood sam-
ples, aorta and lung at 4 hr and 28 d following the 10 d
of inhalation exposure. The initial aim was to evaluate
whole blood cells for a gene network signature of GMA-
SS exposure. Utilizing the specified analysis criteria, 90
and 211 genes eligible for network analysis by Ingenuity
Pathway Analysis (IPA) were altered due to inhalation of
GMA-SS fume at 4 hr and 28 d, respectively. The net-
works, “organismal development, infection mechanism,
antimicrobial response” and “antimicrobial response, in-
flammatory response, post-translational modification”
were the most significant networks at 4 hr (Additional
file 1: Figure S2) and 28 d (Figure 2), respectively. Both
networks consisted of genes related to type I interferon
signaling and a central component to the pathway was
the transcription factor interferon regulatory factor 7
(Irf7) (Additional file 1: Figure S2 and Figure 2;
Additional file 1: Table S1). This effect was evident in
the top differentially regulated genes at 4 hr and 28 d
Figure 1 Characterization of the welding fume exposure. Diagram of the NIOSH welding inhalation system (upper panel): 1) Computer
control and power source, 2) robotic welder and accompanying hardware necessary for fume generation and 3) exposure chamber and
characterization devices. The middle left panel represents the metal content of the GMA-SS fume. The middle right panel shows the particle size
distribution of the generated fume (M=mass concentration and D= aerodynamic diameter). The bottom panels show a scanning electron
micrograph (left) and transmission electron micrograph (right) of the welding fume.
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several type I interferon related genes including Isg15,
Usp18, Ifitm3, Oas1 and Oasl2 were confirmed by qRT-
PCR at these time points (Figure 3A). These effects were
also most prominent in the functional analysis at 4 hr
(data not shown) and 28 d (Additional file 1: Figure S3)
post-exposure. The determination of Irf7 as the central
component was entirely subjective. This claim was sup-
ported by our interpretation of the IPA analysis (e.g. Irf7
gene expression was the highest (4 hr) and second high-
est (28 d) expressed gene in the blood and was primaryto the most significant IPA networks), consistency and
level of expression with time and tissue (e.g. confirma-
tory quantitative real-time RT-PCR), and supportive
information in the literature indicating IRF7 the master
regulator of the type I interferon response [18]. Together
these findings contribute to our claim of Irf7 as a central
signaling component induced by GMA-SS inhalation.
Aorta
Utilizing the analysis criteria, 90 and 165 genes eligible
for network analysis by IPA were altered due to GMA-
Figure 2 Top molecular network in whole blood cells 28 d after GMA-SS inhalation exposure. Gene network analysis by IPA indicated a
significant type I interferon response following exposure. The network contained 25 of 35 focus molecules with a score of 44. A score of 44
means there is a 1 in 1044 chance of this network occurring by random chance. Intensity of the red (upregulated) or green (downregulated) color
indicates level of gene expression. The white color indicates a predicted molecule incorporated from the Ingenuity knowledge base. Gray
represents a molecule present in the dataset, but one that did not meet the specified cutoff criteria.
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the top 2 networks were “antimicrobial response, inflam-
matory response, infection mechanism” and “antimicro-
bial response, inflammatory response, post-translational
modification” showing similarity to the response in the
whole blood cells (data not shown and Figure 4 respect-
ively; Additional file 1: Table S3). The transcription fac-
tor Irf7 was a central molecule in the response of the
aorta. Confirmation by qRT-PCR of type I interferon
related genes showed the effect was still prominent at 14
d post-exposure and resolving toward baseline by 28 d
(Figure 3B). Similar to the blood, the functional analysis
was a reflection of the network analysis described above
(Additional file 1: Figure S4). At 28 d, 164 genes were
eligible for network analysis; however, the above men-
tioned gene networks were not a significant part of the
results (data not shown).
Lung
A major hypothesis of our laboratory is that the systemic
gene signature reflects the ongoing pulmonary response
induced by a particle. Due to the known pulmonary tox-
icity of this exposure regimen [3], significant changes
were expected in the lung tissue. Indeed, 439 and 368
genes eligible for network analysis by IPA were altered
at 4 hr and 28 d post-exposure, respectively. A complete
analysis of the global lung response was not the focus ofthis study, instead whether a type I interferon response
was evident following analysis of the blood and aorta. In
the lung at 4 hr and 28 d, four significant networks (two
at 4 hr and 28 d) indicating infectious disease, anti-
microbial response and infection mechanism were
evident (Figure 5; Additional file 1: Figure S5 highlight
two networks; Additional file 1: Table S4). Correspond-
ing to the blood and aorta, a central component of the
IPA networks was Irf7. Several of the genes were con-
firmed by qRT-PCR (Figure 3C).
Serum protein profiling
A panel of 59 analytes was measured in the serum be-
fore the outcome of the microarray data was learned.
The panel was composed mainly of inflammatory mar-
kers, and interferon alpha and beta were not included;
however, several proteins from the panel complemented
a systemic type 1 interferon response. C-reactive protein
(CRP) and matrix metalloproteinase 9 (MMP-9) were
decreased and oncostatin M (OSM) was increased at
4 hr (Additional file 1: Table S5). By 28 d post-exposure
the changes included decreased immunoglobulin A
(IgA) and a highly significant increase in vascular cell
adhesion molecule-1 (VCAM-1). At both time points
there was a general trend for increased serum inducible
protein 10 (IP-10) (41% at 4 hr and 50% at 28d;
Additional file 1: Table S5).
Figure 3 Confirmation of microarray by qRT-PCR. Relative mRNA expression levels of type I interferon related genes are shown in whole
blood cells (A), aorta (B) and lung (C) in reference to sham (dotted line). *p<0.05 vs sham.
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(PRR) induction
To complement Irf7 induction, the expression of the
type I interferon genes Ifna1 (identifies interferon alpha
1, 5 and 6) and Ifnb1 (interferon beta 1) and the intracel-
lular PRR Ddx58 (DEAD box polypeptide 58; RIG-I) and
Ifih1 (interferon induced with helicase C domain;
MDA5) were evaluated by qRT-PCR. These genes were
increased in the lung at 4 hr and 28 d post exposure
(Figure 6). Another related intracellular PRR, Dhx58
(DEXH box polypeptide 58; LGP2), was increased in the
array data (2.355 fold induction p = 2.89E-09 at 4 hr and
2.157 fold induction p = 2.35E-08 at 28 d). Also, Tlr7 was
increased at both time points (1.271 fold induction
p = 3.12E-04 at 4 hr and 1.369 fold induction p = 1.05E-
05 at 28 d). IPA analysis also revealed a significant IRFcanonical pathway “activation of IRF by cytosolic PRR”
at 4 hr (data not shown) and 28 d (Additional file 1:
Figure S6) illustrating both upstream and downstream
signaling related to Irf7 induction.
Additional PRR induction
In addition to the specific IRF-associated PRR canonical
pathway, IPA analysis showed a network of general PRR
induction in the lung following welding fume inhalation
exposure at 4 hr (data not shown) that was still evident
28 d (Additional file 1: Figure S10) post-exposure. Gene
expression of several other PRR and associated signaling
molecules was induced (Additional file 1: Figure S7;
Additional file 1: Table S6). Microarray analysis indicated
induction of Il1b and Casp1 suggesting NALP3 activa-
tion. Confirmation by qRT-PCR of Nlrp3 and associated
Figure 4 A top molecular network in aorta at 4 hr after GMA-SS inhalation exposure. Gene network analysis by IPA indicated a significant
type I interferon response following exposure. The network contained 18 of 35 focus molecules with a score of 35. A score of 35 means there is a
1 in 1035 chance of this network occurring by random chance. Intensity of the red (upregulated) or green (downregulated) color indicates level
of gene expression. The white color indicates a predicted molecule incorporated from the Ingenuity knowledge base. Gray represents a molecule
present in the dataset, but one that did not meet the specified cutoff criteria.
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cant effects were seen at 28 d after exposure. In this
study, IL-1β was not increased in the serum, but was
increased in a previous exposure at 14 d post [8]
suggesting a peak in the response may have occurred
sometime between 4 hr and 28 d.
Specificity of Irf7 signaling
One question which arose from this methodological ap-
proach was the uniqueness of a consistent molecular sig-
nature, in this case Irf7 and type I interferon signaling
following GMA-SS inhalation exposure, in pulmonary and
extrapulmonary compartments. To gain insight, previous
experimental designs were examined for Irf7, Ddx58 and
Ifih1 induction. A recent study by our group compared
the pulmonary and systemic effects of SS and mild steel
(MS) welding fume by pharyngeal aspiration in male
C57BL/6J mice [19]. At 24 hr post-aspiration of 340 μg of
GMA welding fume, analysis of the lungs showed the
GMA-SS, but not GMA-MS, fume increased Irf7, Ddx58
and Ifih1 gene expression (Figure 7). Also, previous pul-
monary exposures to 40 μg of multi-walled CNT or
single-walled CNT in male C57BL/6J mice [15] showed
no induction of Irf7 or associated PRR (Figure 7). The
exposures to both welding fume and CNT inducedmarked cytotoxicity, measured by bronchoalveolar lavage
lactate dehydrogenase activity (Additional file 1: Figure
S9A), a marked inflammatory response (Additional file 1:
Figure S9B), and inflammatory cell influx [15,19] indicat-
ing a generalized response to inflammation was not likely
contributing to the increase of these specific genes.
Discussion and conclusion
The novel findings of this study include blood cell acti-
vation with dominant type I interferon signaling following
10 d of welding fume inhalation. Similar signaling path-
ways were found in the lung and, interestingly, in the
aorta. Systemically, the response was still measurable 28 d
after the exposure ceased. In addition, gene expression
levels of several pattern recognition receptors and asso-
ciated signaling molecules were increased, including those
directly known to induce Irf7. These results showed an
identifiable uniform network of expression in the blood,
vasculature and lung with a level of specificity to SS weld-
ing fume when compared to other exposures.
Previously, pulmonary toxicity of this exposure regi-
men in a C57BL/6J mouse model was published and
Additional file 1: Table S7 was adapted to illustrate the
response to GMA-SS inhalation [3]. The fume exposure
resulted in cytotoxicity and increased permeability, as
Figure 5 A top molecular network in lung at 28 d after GMA-SS inhalation exposure. Gene network analysis by IPA indicated a significant
type I interferon response following exposure. The network contained 22 of 35 focus molecules with a score of 30. A score of 30 means there is a
1 in 1030 chance of this network occurring by random chance. Intensity of the red (upregulated) or green (downregulated) color indicates level
of gene expression. The white color indicates a predicted molecule incorporated from the Ingenuity knowledge base. Gray represents a molecule
present in the dataset, but one that did not meet the specified cutoff criteria.
Figure 6 Effects of GMA-SS inhalation exposure on pulmonary
type I interferons and associated pattern recognition receptors.
Relative mRNA levels of interferon alpha (Ifna – recognizes interferon
alpha 1, 5 and 6), interferon beta (Ifnb – recognizes interferon beta
1), and the pattern recognition receptors Ddx58 (DEAD box
polypeptide 58; RIG-I) and Ifih1 (interferon induced with helicase C
domain; MDA5) were increased in the lung in reference to sham
(dotted line). *p<0.05 vs sham.
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genase (LDH) activity and albumin, respectively
(Additional file 1: Table S7). These effects were found 1
d after 10 d of inhalation exposure and there was no
resolution at 28 d post-exposure. Polymorphonuclear
leukocytes (PMN) were increased 1 d after exposure and
showed further increased levels at 14 and 28 d
(Additional file 1: Table S7). The exposure also increased
total BAL lymphocytes and macrophages and this re-
sponse was maintained throughout the time course
(Additional file 1: Table S7). These data indicate a sus-
tained inflammatory response with a delayed, but
marked PMN influx. These changes were inconsistent
with type I interferon signaling with time indicating that
pulmonary injury and inflammatory cell influx was likely
not a major contributor to the type I interferon
signaling.
In this study, a single gene network was prominent and
consistent between the lung, whole blood cells and aorta.
This network was reflective of type I interferon signaling
with the transcription factor Irf7 as a central hub. Recent
studies have indicated IRF7 as the master regulator of the
type I interferon response meaning induction of interferon
Figure 7 Effects of multiple different pulmonary exposures on
lung mRNA levels of Irf7 and associated pattern recognition
receptors. Lung RNA extracted from previously published exposures
was assessed post-hoc with respect to the new findings from this
study. Male C57BL/6 J mice were exposed to 340 μg of gas metal
arc – stainless steel (GMA-SS), 340 μg gas metal arc – mild steel
(GMA-MS), 40 μg of multi-walled carbon nanotubes (MWCNT), or
40 μg single-walled carbon nanotubes (SWCNT) (n = 5 or 6 per
group for all exposures) by pharyngeal aspiration and lungs were
harvested 24 hr post-exposure [15,19]. Relative mRNA levels of Irf7
(interferon regulatory factor 7) and the pattern recognition receptors
Ddx58 (DEAD box polypeptide 58; RIG-I) and Ifih1 (interferon
induced with helicase C domain; MDA5) were increased in the lungs
of GMA-SS exposed mice only in reference to sham (dotted line).
*p<0.05 vs sham.
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by induction of interferon-α and -β gene expression in
lungs from GMA-SS-exposed mice. Interestingly, the data
also showed a similar response in the periphery as
increased interferon signaling in both circulating blood
cells and the aorta was measured. In support, decreased
serum CRP and MMP-9, increased VCAM-1 and the gen-
eral increase in IP-10 are all consistent with type I inter-
feron therapy [20-24]. Also, OSM, an interleukin-6 family
member that is released with and enhances the effects of
type I interferons [25], was increased in the serum. There-
fore, the primary response, which originates in the lung,
provided an identifiable systemic gene network signature.
Type I interferons are a class of proteins involved in
the innate immune response which can be induced by
PRR. In this study, three cytoplasmic PRR in the RIG-I-
like receptor family (Ddx58/RIG-I, Ifih1/MDA-5 and
Dhx58/LGP2) were increased as a result of GMA-SS ex-
posure. RIG-I and MDA-5 are known to induce IRF7
while LGP2 inhibits the other two receptors [26]. In
addition, expression of Tlr7, a PRR with the potential to
induce Irf7 [26], was increased. Generally, PRR can be
activated by pathogen-associated molecular patterns
(PAMPs), danger-associated molecular patterns (DAMPs)
and particles [27]. Of the three classes of activators,
PAMPs seem the least likely as activation of the abovedescribed PRR can occur from single stranded RNA, intra-
cellular viral RNA and synthetic dsRNA [27] that, even if
present, would not retain integrity at the >4000 °C at
which the welding fume is generated. Also, the results
from this study do not favor DAMPs, at least acutely,
given that other known pulmonary inflammatory agents
did not increase Irf7 gene expression or related PRR
(Figure 7).
Recently, PRR have been shown to play a role follow-
ing a particulate exposure and the study of associated
mechanisms of activation and subsequent pulmonary
and systemic effects is only beginning. Pulmonary expo-
sures to silica or asbestos have been shown to activate
the cytosolic PRR NALP3 inflammasome, a process
resulting from particle uptake [28-30]. Knockout of the
NALP3 inflammasome has been shown to reduce in-
flammation and fibrosis [28-30]. Pulmonary inflamma-
tion resulting from inhalation of PM for 20 weeks,
instillation of residual oil fly ash or inhalation of
cigarette smoke was attenuated with deficiency of Tlr4
[31-33]. In this study, PRR including the RIG-I family
members, Tlr7, Tlr2, Clec7a, Nlrp3 related genes, and
the scavenger receptor Marco, as well as associated sig-
naling molecules, were increased. These results suggest
a coordination of activated signaling PRR pathways
which mediate a response to an inhaled, inflammatory
particulate. Different extracellular and intracellular bac-
terial and viral pathogens are recognized by multiple
PRR [27] and the same redundancy may be true for the
pulmonary response to particulate exposures.
Particularly intriguing was that exposure to MS weld-
ing fume or CNT, known inflammatory exposures
[14,15,19,34], did not increase Irf7 or specifically related
PRR. On the other hand, high dose (2.5 mg/mouse) in-
stillation exposure to silica was recently shown to induce
pulmonary Irf7 [35]. The appearance that induction of
Irf7 was a direct effect of GMA-SS exposure, while cer-
tainly true acutely, was only addressed at 24 hr after a
single exposure by aspiration. Therefore, induction of
type I interferon signaling by other toxicants in a sec-
ondary fashion to repeated exposures and/or additional
time points post-exposure cannot be excluded. While
this is plausible, an alternate explanation suggests that
silica exposure may result in direct activation of Irf7 as
C57BL/6J mice had increased Irf7 gene expression at 3d,
the earliest post-exposure time point examined [35].
In regards to specificity, a recent study by Nemec et al.
showed that CrVI stimulates Irf7 gene expression by
stimulating Fyn phosphorylation of STAT1 and subse-
quent activation of interferon stimulated gene factor 3
(ISGF3) in human airway epithelial cells [36]. These
effects were independent of type I interferon receptor
activation. Of note, the induction of Irf7 by silica was
type I receptor dependent suggesting a different
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weight of GMA-SS is CrVI [37], the potential mechanism
of inhalation exposure includes direct activation of Irf7
gene expression followed by induction of type I interfer-
ons initiating a positive feedback loop. In addition,
ISGF3, a heterotrimeric complex consisting of STAT1,
STAT2 and IRF9, was induced as illustrated in the IRF
canonical pathway (Additional file 1: Figure S8). The sig-
naling can also account for associated PRR induction be-
cause activation of IRF7 dependent type I interferon
signaling increases RIG-I and MDA5 expression
[26,38,39], although a direct mechanism cannot be
excluded. Therefore, while some PRR may be activated
in a nonspecific manner, such as general particle uptake,
inflammatory and/or oxidative stress mechanisms (e.g.
NALP3, toll-like receptors), some may be uniquely
activated.
Does the increased type I interferon signaling contrib-
ute to the toxicological effects of GMA-SS? One poten-
tial role for Irf7 is inflammation. For example, knockout
of Irf7 in a silica-exposed mouse model decreased
chronic pulmonary inflammation [35], an effect known
to occur after GMA-SS inhalation in an animal model
[2,3]. Since pulmonary inflammation is linked to sys-
temic inflammation and resultant adverse effects, such
as cardiovascular dysfunction [40], Irf7 may not only
contribute to lung inflammation but to these other
effects as well. In support, a recent study by Kampfrath
et al. showed knockout of the PRR Tlr4 not only reduced
pulmonary inflammation, but also blunted systemic in-
flammation and vascular dysfunction following particu-
late matter inhalation [33]. Previous studies have shown
that mice fed a high fat diet had increased Irf7 and
related type I interferon signaling in the aorta [41]. Also,
an IRF7-dependent inflammatory network was asso-
ciated with the pathogenesis of type I diabetes [42] and
infection induced Irf7 in endothelial cells may contribute
to the development of vascular lesions [43]. These stud-
ies suggest that cardiovascular dysfunction and differen-
tial regulation of IRF7 may be linked. Currently, the role
of IRF7 in the vasculature is unknown and additional
studies are warranted.
Interestingly, the pulmonary and systemic induction of
interferon seems counterintuitive to the reported im-
munosuppression following metal-rich fume exposure.
In fact, this study showed decreased serum IgA 28 d
after exposure ended, which supports a previous finding
in human welders [44]. Human welders are more prone
to develop bronchitis and pneumonia, and animal stud-
ies have shown the inability to clear L. monocytogenes
after welding inhalation exposure [1,2,13]. Since GMA-
SS, GMA-MS or CNT exposure induce localized im-
munosuppression [2,13,45], but only GMA-SS induced
type I interferon signaling, a general compensatoryupregulation in response to a dampened immune system
seems unlikely. In fact, the exact opposite may be true.
Type I interferon receptor knockout mice are resistant
to L. monocytogenes exposure [46]. This provides a direct
mechanistic link of CrVI exposure to a suppressed lung
defense via IRF7 and also can explain why L. monocyto-
genes, under exactly the same exposure conditions, pro-
duced a greater effect in SS as compared to MS fumes
[2,13]. Finally, chronic elevation of type I interferons,
although utilized therapeutically, has the potential to
cause immunosuppression [47,48], supporting the effects
found in humans and animal studies.
The aim of this study was to analyze lung, whole blood
cells and the vasculature for a related, identifiable mo-
lecular pathway related to GMA-SS exposure. Our
expectations were exceeded by the consistency of the re-
sponse that also proved to have some specificity. Our
data, combined with Nemec et al. (2010), suggests the
IRF7-dependent signaling network was conserved across
species and consistent over time and between tissues.
Therefore, utilization of this methodological approach
has the potential to identify consistent, prominent and/
or novel pathways induced by a toxicant exposure. The
gene network(s) may then be manipulated to address
direct pulmonary and extrapulmonary effects. Even if
the identified network(s) does not contribute to marked
exposure effects, it could be used for exposure monitor-
ing. In this study, the systemic measure of Irf7 and type
I signaling become a surrogate marker of GMA-SS fume
exposure.
Methods
Study design and exposure
Male C57BL/6J mice from Jackson Laboratory (Bar Har-
bor, ME) were used in this study. All mice were provided
food and tap water ad libitum in ventilated cages in a
controlled humidity and temperature environment with
a 12 hr light/dark cycle. Animal care and use procedures
were conducted in accordance with the “PHS Policy on
Humane Care and Use of Laboratory Animals” and the
“Guide for the Care and Use of Laboratory Animals”
(NIH publication 86–23, 1996). These procedures were
approved by the National Institute for Occupational
Safety and Health Institutional Animal Care and Use
Committee.
C57BL/6J mice, 6 weeks of age, were exposed by inhal-
ation to gas metal arc-stainless steel (GMA-SS) welding
fume at 40 mg/m3 for 3 hr/d for 5 d a week for two
weeks (exposures day 1–5 and 8–12). The welding fume
generation system and characterization for this particu-
lar fume has been extensively described [2,49]. Mice
were sacrificed by carbon dioxide asphyxiation at 4 hr
(n = 4 air; n = 4 GMA-SS), 14 d (n = 4 air; n = 4 GMA-SS)
and 28 d (n = 8 air; n = 8 GMA-SS) post-exposure.
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bal expression analysis at 4 hr and 28 d post exposure.
The aorta was collected from all time points. All samples
were stored at −80 °C prior to analysis. Serum was col-
lected 4 hr and 28 d post exposure and sent to Myriad/
RBM (Austin, TX) for protein profiling by multiplex im-
munoassay RodentMAP v2.0.
Gene expression
RNA was isolated from whole lung homogenates using
the TRIzol (Invitrogen, Carlsbad, CA) method and then
cleaned according to the manufacturer’s instructions
using a RNeasy Mini Kit (Qiagen, Valencia, CA, USA).
The aorta was homogenized with a Qiagen Tissue Lyser
and RNA was isolated using the RNeasy fibrous tissue
mini kit (Qiagen). Whole blood RNA was isolated using
the Mouse RiboPureTM Blood RNA Isolation Kit
(Ambion, Austin, TX, USA) according to manufacturer’s
directions and globin RNA was removed using the GLO-
BINclearTM kit (Ambion). A 2 μl aliquot of each RNA
sample was quantified using a NanoDrop ND-1000 spec-
trophotometer (NanoDrop Technologies, Inc., Wilming-
ton, DE, USA) and quality was assessed on the Agilent
2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA,
USA).
Labeled cRNA, from an input RNA of 375 ng, was
prepared according to the manufacture’s protocol, using
the Illumina TotalPrep RNA Amplification Kit (Ambion,
Catalog #IL1791) for hybridization to the arrays. The la-
beled cRNA samples were then assessed for quality and
quantity. To ensure consistency for the array hybridization,
all cRNA samples for each time point were quantified at
the same time. The MouseRef-8 v2.0 beadchip contains
>24,000 well annotated RefSeq transcripts and allows eight
samples to be interrogated in parallel. After a 20 hr
hybridization period at 58 °C, the beadchips were scanned
using an Illumina BeadStation 500 G - BeadArray Reader
(Illumina, Inc., San Diego, CA, USA). The microarray data
were deposited to Gene Expression Omnibus (GEO)
(http://www.ncbi.nlm.nih.gov/geo/) and are accessible
through accession number GSE34056.
Confirmation of microarray results by quantitative
real-time reverse transcription polymerase chain reac-
tion (qRT-PCR) was done as follows. Evaluation of gene
expression was determined by standard 96-well technol-
ogy using the StepOne™ (Applied Biosystems, Carlsbad,
CA, USA) with pre-designed Assays-on-Demand™ Taq-
ManW probes and primers (Applied Biosystems). Using
96 well plates, one μg of total RNA was reverse tran-
scribed using random hexamers (Applied Biosystems)
and Superscript III (Invitrogen, Carlsbad, CA). Nine μl
of cDNA (1/10) was then used for gene expression de-
termination. Hypoxanthine-guanine phosphoribosyltrans-
ferase was used as an internal reference. Relative geneexpression was calculated using the comparative threshold
method (2-ΔΔCt) with vehicle treated mice serving as the
reference group [50].
Hierarchial clustering and heatmap generation
Heatmaps were generated using the ‘pheatmap’ package in
R using the correlation distance measure and complete
linkage for the construction of the dendrograms. Genes
with a nominal p-value of less than 0.05 and a fold change
of at +/− 1.1 were included in the map.
Statistics and data analysis strategy
Statistical analysis procedures for whole microarray data-
sets have been extensively described [51]. Briefly, samples
were imported into illuminaW Beadstudio 3.0.19.0 and
reference, hybridization control, stringency and negative
control genes were checked for proper chip detection.
Beadarray expression data were then exported with mean
fluorescent intensity across like beads and bead variance
estimates into flat files for subsequent analysis. Illumina
BeadArray expression data were analyzed in Bioconductor
using the ‘lumi’ and ‘limma’ packages. Gene lists contain-
ing group means of expression, p-values and standard fold
changes were utilized as input for subsequent bioinfor-
matics analysis.
The networks and functional analyses were generated
through the use of Ingenuity Pathways Analysis (Inge-
nuityW Systems, www.ingenuity.com). Whole datasets
containing gene identifiers and corresponding expression
values were uploaded into the application and a core
analysis was done. Each identifier was mapped to its cor-
responding object in Ingenuity's Knowledge Base. In this
study the following analysis criteria were utilized: whole
blood cells (fold change = 1.1, p<0.05), aorta (fold
change = 1.1, p<0.05) and lung (1.3 fold change,
p<0.05). The criteria were chosen because it provided
the best representation of the IPA analysis. For the
whole blood cells and aorta, additional analysis including
a more stringent p value (p<0.02), higher fold change
(1.3 fold) or all significant genes (p<0.05) showed a sig-
nificant type I interferon response (data not shown). Pre-
vious analysis showed that the chosen criteria for the
lung were optimal [51]. These differentially regulated
genes, called Network Eligible Molecules, were overlaid
onto a global molecular network developed from infor-
mation contained in Ingenuity’s Knowledge Base. Net-
works of these molecules were then algorithmically
generated based on their connectivity.
The data presented in this manuscript was selected to
represent the type I interferon/IRF7 response induced by
GMA-SS inhalation since the signaling was prominent
in the lung and systemically. An additional manuscript is
being written to include a broader analysis of the micro-
array results and will include time comparisons, a
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ated for the lung, blood and aorta, and a detailed ana-
lysis of the pulmonary response.
The Functional Analysis identified the biological func-
tions and/or diseases that were most significant to the
data set. Molecules from the dataset that met the cutoff
criteria defined above and were associated with bio-
logical functions and/or diseases in Ingenuity’s Know-
ledge Base were considered for the analysis. Right-tailed
Fisher’s exact test was used to calculate a p-value deter-
mining the probability that each biological function and/
or disease assigned to that data set is due to chance
alone. Canonical pathways analysis identified the path-
ways from the Ingenuity Pathways Analysis library of ca-
nonical pathways that were most significant to the data
set. Molecules from the data set that met the cutoff cri-
teria defined above and were associated with a canonical
pathway in Ingenuity’s Knowledge Base were considered
for the analysis. The significance of the association be-
tween the data set and the canonical pathway was mea-
sured in 2 ways: 1) A ratio of the number of molecules
from the data set that map to the pathway divided by
the total number of molecules that map to the canonical
pathway is displayed. 2) Fisher’s exact test was used to
calculate a p-value determining the probability that the
association between the genes in the dataset and the ca-
nonical pathway is explained by chance alone.
Since the consistent signaling pathway was evident in
multiple tissues at more than one time point with vary-
ing stringency, confirmed by qRT-PCR and induced by a
completely separate exposure regimen (Figure 7), the
representation and interpretation of the results are thor-
oughly supported. For analysis other than microarray, all
data are presented as means ± standard error. Since each
time point contained respective controls and were har-
vested separately, all data were compared as sham versus
exposed by Student’s t-test at each time point. Differ-
ences were considered statistically significant at p<0.05.
Additional files
Additional file 1: Contains additional data to supplement the
microarray and pathway analysis data presented in the results
section.
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